80 related articles for article (PubMed ID: 10528203)
41. Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis.
Szeliga J; Daniel DS; Yang CH; Sever-Chroneos Z; Jagannath C; Chroneos ZC
Tuberculosis (Edinb); 2008 Jan; 88(1):7-20. PubMed ID: 17928269
[TBL] [Abstract][Full Text] [Related]
42. Tumor necrosis factor-alpha antagonism by the murine tumor necrosis factor-alpha receptor 2-Fc fusion protein exacerbates histoplasmosis in mice.
Deepe GS
J Interferon Cytokine Res; 2007 Jun; 27(6):471-80. PubMed ID: 17572011
[TBL] [Abstract][Full Text] [Related]
43. Advances in combating fungal diseases: vaccines on the threshold.
Cutler JE; Deepe GS; Klein BS
Nat Rev Microbiol; 2007 Jan; 5(1):13-28. PubMed ID: 17160002
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-1 and host control of pulmonary histoplasmosis.
Deepe GS; McGuinness M
J Infect Dis; 2006 Sep; 194(6):855-64. PubMed ID: 16941354
[TBL] [Abstract][Full Text] [Related]
45. Pulmonary V beta 4+ T cells from Histoplasma capsulatum-infected mice respond to a homologue of Sec31 that confers a protective response.
Scheckelhoff MR; Deepe GS
J Infect Dis; 2006 Mar; 193(6):888-97. PubMed ID: 16479524
[TBL] [Abstract][Full Text] [Related]
46. T cells require tumor necrosis factor-alpha to provide protective immunity in mice infected with Histoplasma capsulatum.
Deepe GS; Gibbons RS
J Infect Dis; 2006 Jan; 193(2):322-30. PubMed ID: 16362898
[TBL] [Abstract][Full Text] [Related]
47. Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum.
Allen HL; Deepe GS
J Clin Invest; 2005 Oct; 115(10):2875-85. PubMed ID: 16151533
[TBL] [Abstract][Full Text] [Related]
48. Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis.
Medeiros AI; Sá-Nunes A; Soares EG; Peres CM; Silva CL; Faccioli LH
Infect Immun; 2004 Mar; 72(3):1637-44. PubMed ID: 14977971
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of interleukin-4 in lungs of mice impairs elimination of Histoplasma capsulatum.
Gildea LA; Gibbons R; Finkelman FD; Deepe GS
Infect Immun; 2003 Jul; 71(7):3787-93. PubMed ID: 12819061
[TBL] [Abstract][Full Text] [Related]
50. Cellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum.
Deepe GS; Gibbons RS
Infect Immun; 2002 Jul; 70(7):3759-67. PubMed ID: 12065519
[TBL] [Abstract][Full Text] [Related]
51. Protective efficacy of H antigen from Histoplasma capsulatum in a murine model of pulmonary histoplasmosis.
Deepe GS; Gibbons R
Infect Immun; 2001 May; 69(5):3128-34. PubMed ID: 11292732
[TBL] [Abstract][Full Text] [Related]
52. Recombinant murine granulocyte-macrophage colony-stimulating factor modulates the course of pulmonary histoplasmosis in immunocompetent and immunodeficient mice.
Deepe GS; Gibbons R
Antimicrob Agents Chemother; 2000 Dec; 44(12):3328-36. PubMed ID: 11083636
[TBL] [Abstract][Full Text] [Related]
53. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-alpha plays a critical role in maintaining secondary immunity in the absence of IFN-gamma.
Zhou P; Miller G; Seder RA
J Immunol; 1998 Feb; 160(3):1359-68. PubMed ID: 9570555
[TBL] [Abstract][Full Text] [Related]
54. Protective and memory immunity to Histoplasma capsulatum in the absence of IL-10.
Deepe GS; Gibbons RS
J Immunol; 2003 Nov; 171(10):5353-62. PubMed ID: 14607938
[TBL] [Abstract][Full Text] [Related]
55. GM-CSF as a therapeutic target in inflammatory diseases.
van Nieuwenhuijze A; Koenders M; Roeleveld D; Sleeman MA; van den Berg W; Wicks IP
Mol Immunol; 2013 Dec; 56(4):675-82. PubMed ID: 23933508
[TBL] [Abstract][Full Text] [Related]
56. [Genetic control of hypereosinophilias].
Granel B; Disdier P; Schleinitz N; Chevillard C; Harle JR; Dessein A; Weiller PJ
Med Trop (Mars); 1998; 58(4 Suppl):508-11. PubMed ID: 10410376
[TBL] [Abstract][Full Text] [Related]
57. Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsulatum.
Deepe GS; Gibbons R; Woodward E
J Immunol; 1999 Nov; 163(9):4985-93. PubMed ID: 10528203
[TBL] [Abstract][Full Text] [Related]
58. Blockade of endogenous TNF-alpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms.
Allendoerfer R; Deepe GS
J Immunol; 1998 Jun; 160(12):6072-82. PubMed ID: 9637524
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
